7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus
Authors:
- Cynthia AranowCACynthia Aranow
- 1 August 1998
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Rheumatology
- Vol. 12 (3) , 495-510
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993American Journal of Epidemiology, 1997
- Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced OsteoporosisNew England Journal of Medicine, 1997
- Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodiesLupus, 1997
- Can Women with Systemic Lupus Erythematosus Safely Use Exogenous Estrogens?JCR: Journal of Clinical Rheumatology, 1995
- Corticosteroids and peptic ulcer: meta‐analysis of adverse events during steroid therapyJournal of Internal Medicine, 1994
- Steroid myopathy in connective tissue diseaseThe American Journal of Medicine, 1976
- Nonassociation of Adrenocorticosteroid Therapy and Peptic UlcerNew England Journal of Medicine, 1976
- The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapyThe American Journal of Medicine, 1975
- Hyperosmolar Anacidotic Coma in Association With Glucocorticoid TherapyJAMA, 1967
- Cataracts and Topical CorticosteroidsAmerican Journal of Ophthalmology, 1964